Works matching IS 15257304 AND DT 2024 AND VI 25 AND IP 8

Results: 10

Osimertinib-Related QTc Prolongation: Real-World Incidence and Impact of Drug Dosing on Recurrence Risk.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 738, doi. 10.1016/j.cllc.2024.06.012

By:

Chen, Olivia H.;
Wong, Wesley K. Y.;
Mok, Kevin K. S.;
Chan, Landon L.;
Tang, Candy;
Li, Molly S. C.

Publication type:

Article

Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET Exon 14 Skipping Mutations and Other MET-Alterations.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 732, doi. 10.1016/j.cllc.2024.07.002

By:

Lara, Matthew S.;
Riess, Jonathan W.;
Goldman, Jonathan W.;
Jiang, Fei;
Bivona, Trever G.;
Blakely, Collin M.

Publication type:

Article

Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM).

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 723, doi. 10.1016/j.cllc.2024.09.005

By:

Enrico, Diego;
Gomez, Juan Elias;
Aguirre, Danilo;
Tissera, Natalia Soledad;
Tsou, Florencia;
Pupareli, Carmen;
Peralta Tanco, Delfina;
Waisberg, Federico;
Rodríguez, Andrés;
Rizzo, Manglio;
Minatta, Nicolás;
Rafael, Picon;
Basbus, Luis;
Lupinacci, Lorena;
Kaen, Diego;
Ramos, Mauro;
Bluthgen, Virginia;
Castagneris, Nicolas;
Coppola, María Pía;
Scocimarro, Alejandra

Publication type:

Article

Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 712, doi. 10.1016/j.cllc.2024.09.001

By:

Watson, Alexander S.;
Krause, Harris B.;
Elliott, Andrew;
Farrell, Alex;
Liu, Stephen V.;
Ma, Patrick C.;
VanderWalde, Ari;
Sledge, George W.;
Spetzler, David;
Schenk, Erin L.;
Camidge, D. Ross

Publication type:

Article

Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors from the Population-Based UK Biobank Study.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 705, doi. 10.1016/j.cllc.2024.08.017

By:

Graber-Naidich, Anna;
Eunji Choi;
Wu, Julie T.;
Ellis-Caleo, Timothy J.;
Neal, Joel;
Wakelee, Heather A.;
Kurian, Allison W.;
Han, Summer S.

Publication type:

Article

Understanding the Social Risk Factors That Avert Equitable Lung Cancer Care.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 699, doi. 10.1016/j.cllc.2024.08.011

By:

Kapp, Christopher M.;
Green, Chelsi;
Thiboutot, Jeffrey;
Kim, Jeremy;
Pasquinelli, Mary M.;
Aronson, Benjamin;
Argento, A. Christine

Publication type:

Article

Efficacy of Prophylactic Cranial Irradiation in Early to Mid-stage Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 690, doi. 10.1016/j.cllc.2024.08.005

By:

Jianjiang Liu;
Yang Yang;
Dongping Wu;
Hongru Li

Publication type:

Article

Association Between PD-L1 Score and the Outcomes of Consolidation Durvalumab in a Large Nationwide Series of Patients With Stage III NSCLC Treated With Chemoradiotherapy.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 683, doi. 10.1016/j.cllc.2024.07.013

By:

Damhuis, Ronald;
Bahce, Idris;
Senan, Suresh

Publication type:

Article

Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After EGFR Inhibition.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 672, doi. 10.1016/j.cllc.2024.07.012

By:

Acker, Fabian;
Klein, Alexandra;
Rasokat, Anna;
Eisert, Anna;
Kron, Anna;
Christopoulos, Petros;
Stenzinger, Albrecht;
Kulhavy, Jonas;
Hummel, Horst-Dieter;
Waller, Cornelius F.;
Hummel, Anne;
Rittmeyer, Achim;
Kropf-Sanchen, Cornelia;
Zimmermann, Heiner;
Lörsch, Alisa;
Kauffmann-Guerrero, Diego;
Schütz, Maret;
Herster, Franziska;
Thielert, Franziska;
Demes, Melanie

Publication type:

Article

Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study.

Published in:

Clinical Lung Cancer, 2024, v. 25, n. 8, p. 661, doi. 10.1016/j.cllc.2024.07.001

By:

Yosuke Kakiuchi;
Koichi Saruwatari;
Kenta Murotani;
Takaaki Tokito;
Toyohisa Iriki;
Jun Iwakawa;
Yoshihiko Sakata;
Naoki Shingu;
Sho Saeki;
Megumi Inaba;
Akira Takaki;
Shunsuke Misono;
Takayuki Suetsugu;
Koichi Azuma;
Keiko Mizuno;
Takuro Sakagami

Publication type:

Article